Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

46.02
Delayed Data
As of May 24
 +2.56 / +5.89%
Today’s Change
35.78
Today|||52-Week Range
81.28
-40.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues39.1M85.6M197.7M249.0M
 
 
 
 
 
Cost of Goods Sold26.5M49.0M67.4M60.4M
 
 
 
 
 
Depreciation And Amortization5.6M5.7M10.0M11.5M
 
 
 
 
 
 
Operating ExpensesGross Income6.9M30.8M120.2M177.2M
 
 
 
 
 
General Expenses56.2M84.1M125.4M167.7M
 
 
 
 
 
Research And Development9.9M21.6M18.7M28.7M
 
 
 
 
 
Total Operating Expenses88.4M138.8M202.8M239.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-49.3M-53.3M-5.2M9.5M
 
 
 
 
 
Extraordinary Charge-1.1M-3.4M0.00-52.0K
 
 
 
 
Interest Expense On Debt2.1M9.0M9.0M8.6M
 
 
 
 
 
Other Expenses-111.0K-47.0K-159.0K-165.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-52.3M-64.4M-13.5M2.1M
 
 
 
 
 
Income Taxes0.00-442.0K-173.0K-264.0K
 
 
 
 
Net Income-52.3M-63.9M-13.7M1.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS30.3M33.2M35.3M36.5M
 
 
 
 
 
Shares To Calculate EPS Diluted30.3M33.2M35.3M41.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.72-$1.93-$0.39$0.04
 
 
 
 
 
EPS Diluted-$1.72-$1.93-$0.39$0.04